1817-88-5

Usage

Uses

Used in Pharmaceutical Industry:
2-(CYCLOHEXYLOXY)ETHANOL 99 is used as a pharmaceutical intermediate for the synthesis of various drugs and active pharmaceutical ingredients. Its unique structure allows for the development of new drug candidates with potential therapeutic benefits.
Used in Chemical Synthesis:
In the chemical industry, 2-(CYCLOHEXYLOXY)ETHANOL 99 serves as a key intermediate in the synthesis of a wide range of organic compounds. Its reactive functional groups enable it to participate in various chemical reactions, leading to the formation of new molecules with diverse applications.
Used in Flavor and Fragrance Industry:
2-(CYCLOHEXYLOXY)ETHANOL 99 is used as a building block in the creation of unique fragrances and flavors. Its distinct chemical structure allows for the development of novel scents and tastes that can be incorporated into various consumer products.
Used in Material Science:
In the field of material science, 2-(CYCLOHEXYLOXY)ETHANOL 99 can be utilized in the development of new materials with specific properties. Its cyclohexyloxyethanol structure can contribute to the formation of polymers, coatings, and other materials with unique characteristics.
Overall, 2-(CYCLOHEXYLOXY)ETHANOL 99 is a versatile organic compound with a wide range of applications across various industries, including pharmaceuticals, chemical synthesis, flavor and fragrance, and material science. Its unique structure and properties make it a valuable intermediate and building block for the development of new products and technologies.

InChI:InChI=1/C8H16O2/c9-6-7-10-8-4-2-1-3-5-8/h8-9H,1-7H2

Upstream product

• 177-10-6 1,3-dioxolane-2-spirocyclohexane 
• 60-29-7 diethyl ether 
• 71995-54-5 2-(cyclohexyloxy)acetic acid 
• 105-36-2 ethyl bromoacetate 
• 108-93-0 cyclohexanol 
• 22096-22-6 sodium cyclohexanolate 
• 107-07-3 2-chloro-ethanol 
• 7446-70-0 aluminium trichloride 
• 108-94-1 cyclohexanone 
• 107-21-1 ethylene glycol 
• 98428-56-9 methanesulfonic acid cyclohexylidenehydrazide 
• 100-99-2 triisobutylaluminum 

Downstream Products

• 53067-04-2 2-(cyclohexyloxy)ethylchloride 
• 94434-59-0 Ethylenglycol-undecylether-cyclohexylether 
• 93815-52-2 Ethylenglycol-nonylether-cyclohexylether 
• 932-92-3 cyclohexyl ethyl ether 
• 16654-73-2 2-(Cyclohexyloxy)-ethyl-trimethylsilylether 
• 145798-42-1 2-(cyclohexyloxy)ethyl-4-methylbenzenesulfonate 
• 1221413-91-7 4-(2-(cyclohexyloxy)ethoxy)benzaldehyde 
• 200400-39-1 N-[1-(2-cyclohexyloxy-ethylcarbamoyl)-2-hydroxy-ethyl]-4-(pyridine-3-carbonyl)-benzamide 
• 200400-47-1 (S)-2-[4-(Pyridine-3-carbonyl)-phenyl]-4,5-dihydro-oxazole-4-carboxylic acid (2-cyclohexyloxy-ethyl)-amide 
• 200400-55-1 N-<2-(cyclohexyloxy)ethyl>-2-<4-(3-pyridylcarbonyl)phenyl>-4-oxazolecarboxamide 
• 200400-22-2 2-amino-N-(2-cyclohexyloxy-ethyl)-3-hydroxy-propionamide 
• 90226-63-4 2-(cyclohexyloxy)ethylamine 
• 137211-72-4 methanesulfonic acid 2-cyclohexyloxy-ethyl ester 

Relevant academic research and scientific papers

Chitosan grafted with a heteropolyanion-based ionic liquid as an effective and reusable catalyst for acetalization

Chitosan immobilized with an acidic ionic liquid (CS-VImPS-PW) was fabricated via a radical addition reaction of N-vinylimidazoliumpropane sulfonate and chitosan, followed by acidification with a heteropolyacid. It was characterized by a Fourier transform infrared spectrometer, solid-state 13C nuclear magnetic resonance spectrometer, thermogravimetric analyzer, elemental analyzer, and Hammett indicator. Some acetalization reactions were investigated to evaluate the catalytic activity of CS-VImPS-PW. The results show that CS-VImPS-PW is highly active for the acetalization reactions in high acetal yields ranging from 83.2 to 96.2% and can be reused 8 times without noticeable loss of activity.

Glucopyranosyl derivative and application thereof in medicines

The invention relates to a glucopyranosyl derivative used as a sodium-dependent glucose transporter (SGLT) inhibitor, a medicinal composition containing the derivative, and an application of the derivative and the medicinal composition in medicines, and especially relates to the glucopyranosyl derivative represented by formula (I) or a pharmaceutically acceptable salt or all stereoisomers thereof, or the medicinal composition containing the derivative, and a use of the derivative and the medicinal composition in the preparation of medicines for treating diabetes and diabetes related diseases.

SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF

Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

Reductive cleavage of acetals/ketals with ZrCl4/NaBH4

Reductive cleavage of acetals/ketals with zirconium tetrachloride- sodium borohydride leading to the formation of ether alcohols is described.

ZrCl4-catalyzed scission of ethylene acetals with organoaluminum compounds

Ethylene acetals and ethylene ketals undergo reductive scission under the action of Bui2AlH in the presence of catalytic amounts of ZrCl4. With Et3Al and Bui3Al, reductive alkylation also occurs.

A mild and simple procedure for the reductive cleavage of acetals and ketals

A convenient, mild and simple procedure, employing sodium cyanoborohydride in the presence of either catalytic or stoichiometric amount of boron trifluoride etherate in dry THF, for the reductive cleavage of the acetals and ketals is described.

REDUCTION OF ACETALS WITH CpTiCl3-LiAlH4

The reduction of cyclic acetals and ketals derived from aromatic or aliphatic aldehydes and ketones with CpTiCl3-LiAlH4 system in diethyl ether at 30 deg C affords the corresponding hydroxyethyl ethers and the corresponding alkyl benzene or aliphatic hydrocarbons.